Autobio Diagnostics Co Ltd (603658) — Working Capital to Net Assets Ratio
Autobio Diagnostics Co Ltd (603658) has a Working Capital to Net Assets ratio of 41.2% as of March 2026. Working capital of CN¥3.82 Billion (current assets of CN¥6.09 Billion minus current liabilities of CN¥2.28 Billion) is measured against net assets of CN¥9.26 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Autobio Diagnostics Co Ltd to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Autobio Diagnostics Co Ltd Working Capital to Net Assets (2011–2025)
This chart shows how Autobio Diagnostics Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 41.2%, reflecting working capital of CN¥3.82 Billion against net assets of CN¥9.26 Billion CNY. For the complete balance sheet picture, see 603658 asset base.
Annual Working Capital to Net Assets for Autobio Diagnostics Co Ltd (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Autobio Diagnostics Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Autobio Diagnostics Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.8% | CN¥3.68 Billion | CN¥9.02 Billion | CN¥6.31 Billion | CN¥2.63 Billion | ▼ -3.9 pp |
| 2024 | 44.7% | CN¥3.88 Billion | CN¥8.69 Billion | CN¥6.54 Billion | CN¥2.66 Billion | ▼ -3.0 pp |
| 2023 | 47.7% | CN¥4.13 Billion | CN¥8.67 Billion | CN¥6.61 Billion | CN¥2.48 Billion | ▼ -4.0 pp |
| 2022 | 51.7% | CN¥4.09 Billion | CN¥7.91 Billion | CN¥6.25 Billion | CN¥2.17 Billion | ▼ -3.7 pp |
| 2021 | 55.4% | CN¥4.10 Billion | CN¥7.40 Billion | CN¥5.56 Billion | CN¥1.46 Billion | ▼ -2.9 pp |
| 2020 | 58.3% | CN¥3.84 Billion | CN¥6.59 Billion | CN¥5.09 Billion | CN¥1.26 Billion | ▲ +19.2 pp |
| 2019 | 39.1% | CN¥1.03 Billion | CN¥2.63 Billion | CN¥2.02 Billion | CN¥987.04 Million | ▲ +13.8 pp |
| 2018 | 25.3% | CN¥496.63 Million | CN¥1.97 Billion | CN¥1.11 Billion | CN¥610.79 Million | ▼ -3.5 pp |
| 2017 | 28.8% | CN¥486.01 Million | CN¥1.69 Billion | CN¥913.69 Million | CN¥427.69 Million | ▼ -33.7 pp |
| 2016 | 62.4% | CN¥1.03 Billion | CN¥1.64 Billion | CN¥1.18 Billion | CN¥148.34 Million | ▲ +22.9 pp |
| 2015 | 39.5% | CN¥284.00 Million | CN¥718.55 Million | CN¥414.64 Million | CN¥130.64 Million | ▲ +0.3 pp |
| 2014 | 39.3% | CN¥196.68 Million | CN¥500.94 Million | CN¥290.76 Million | CN¥94.08 Million | ▼ -6.6 pp |
| 2013 | 45.9% | CN¥156.27 Million | CN¥340.42 Million | CN¥215.32 Million | CN¥59.05 Million | ▼ -12.0 pp |
| 2012 | 57.9% | CN¥135.47 Million | CN¥233.84 Million | CN¥170.08 Million | CN¥34.61 Million | ▼ -6.5 pp |
| 2011 | 64.4% | CN¥101.15 Million | CN¥156.96 Million | CN¥126.50 Million | CN¥25.34 Million | — |